6
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      A system for reporting and evaluating adverse drug reactions of herbal medicine in Taiwan from 1998 to 2016

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The Taiwan Adverse Drug Reaction Reporting System for Herbal Medicine (TADRRS-HM) has systematically documented suspected adverse events from adverse drug reaction (ADR) reports from 1998 (prior to its formal establishment in 2001) and evaluates safety profiles of herbal medicines. This article describes findings from 2079 ADR reports filed between 1998 and 2016: 941 reports involved single herbs and 87 involved folk herbals; 842 were generated from clinical trials, while 209 ADR reports involving foods, health foods, dietary supplement foods and herbal cuisine were grouped as Other. Severity assessments using the Modified Hartwig and Siegel scale classified 72.4% of ADRs as mild, 17.4% as moderate and 6.5% as severe. System Organ Class classification of the ADRs identified gastrointestinal system disorders as the most common (33.4%), followed by skin and subcutaneous tissue disorders (21.2%). The TADRRS-HM records indicate that herbal medicines may cause a wide range of ADRs. Aconiti Radix, Xiao-Qing-Long-Tang, and Datura suaveolens were the most commonly reported single herb, herbal formula, and folk herbal, respectively. The data indicate that herbal medicines may cause a wide range of ADRs. This system will confer long-term benefits for the development of Taiwan’s herbal medicines adverse reaction database and facilitate epidemiological analysis.

          Related collections

          Most cited references41

          • Record: found
          • Abstract: not found
          • Article: not found

          A method for estimating the probability of adverse drug reactions

            Bookmark
            • Record: found
            • Abstract: not found
            • Article: not found

            Preventability and severity assessment in reporting adverse drug reactions.

              Bookmark
              • Record: found
              • Abstract: found
              • Article: found
              Is Open Access

              RUCAM in Drug and Herb Induced Liver Injury: The Update

              RUCAM (Roussel Uclaf Causality Assessment Method) or its previous synonym CIOMS (Council for International Organizations of Medical Sciences) is a well established tool in common use to quantitatively assess causality in cases of suspected drug induced liver injury (DILI) and herb induced liver injury (HILI). Historical background and the original work confirm the use of RUCAM as single term for future cases, dismissing now the term CIOMS for reasons of simplicity and clarity. RUCAM represents a structured, standardized, validated, and hepatotoxicity specific diagnostic approach that attributes scores to individual key items, providing final quantitative gradings of causality for each suspect drug/herb in a case report. Experts from Europe and the United States had previously established in consensus meetings the first criteria of RUCAM to meet the requirements of clinicians and practitioners in care for their patients with suspected DILI and HILI. RUCAM was completed by additional criteria and validated, assisting to establish the timely diagnosis with a high degree of certainty. In many countries and for more than two decades, physicians, regulatory agencies, case report authors, and pharmaceutical companies successfully applied RUCAM for suspected DILI and HILI. Their practical experience, emerging new data on DILI and HILI characteristics, and few ambiguous questions in domains such alcohol use and exclusions of non-drug causes led to the present update of RUCAM. The aim was to reduce interobserver and intraobserver variability, to provide accurately defined, objective core elements, and to simplify the handling of the items. We now present the update of the well accepted original RUCAM scale and recommend its use for clinical, regulatory, publication, and expert purposes to validly establish causality in cases of suspected DILI and HILI, facilitating a straightforward application and an internationally harmonized approach of causality assessment as a common basic tool.
                Bookmark

                Author and article information

                Contributors
                tcmchh55@gmail.com
                htchu@asia.edu.tw
                Journal
                Sci Rep
                Sci Rep
                Scientific Reports
                Nature Publishing Group UK (London )
                2045-2322
                2 November 2021
                2 November 2021
                2021
                : 11
                : 21476
                Affiliations
                [1 ]GRID grid.254145.3, ISNI 0000 0001 0083 6092, Graduate Institute of Integrated Medicine, College of Chinese Medicine, and Chinese Medicine Research Center, , China Medical University, ; No. 91, Hsueh-Shih Road, North District, Taichung, 40402 Taiwan, ROC
                [2 ]GRID grid.411508.9, ISNI 0000 0004 0572 9415, Department of Chinese Medicine, , China Medical University Hospital, ; Taichung, Taiwan
                [3 ]GRID grid.254145.3, ISNI 0000 0001 0083 6092, School of Chinese Medicine, College of Chinese Medicine, , China Medical University, ; Taichung, Taiwan
                [4 ]GRID grid.254145.3, ISNI 0000 0001 0083 6092, Department of Public Health, College of Public Health, , China Medical University, ; Taichung, Taiwan
                [5 ]GRID grid.411508.9, ISNI 0000 0004 0572 9415, Division of Chinese Internal Medicine, Department of Chinese Medicine, , China Medical University Hospital, ; Taichung, Taiwan
                [6 ]GRID grid.145695.a, ISNI 0000 0004 1798 0922, School of Traditional Chinese Medicine, , Chang Gung University, ; Taoyuan, Taiwan
                [7 ]GRID grid.411508.9, ISNI 0000 0004 0572 9415, Traditional Chinese Medicine Pharmacy, , China Medical University Hospital, ; Taichung, Taiwan
                [8 ]Traditional Chinese Medicine Pharmacy, Taipei City Hospital, Taipei, Taiwan
                [9 ]GRID grid.411508.9, ISNI 0000 0004 0572 9415, Department of Pharmacy, , China Medical University Hospital, ; Taichung, Taiwan
                [10 ]GRID grid.254145.3, ISNI 0000 0001 0083 6092, School of Pharmacy, College of Pharmacy, , China Medical University, ; Taichung, Taiwan
                [11 ]Department of Traditional Chinese Medicine, Chinese Medicine Department, China Medicine University Hospital, Taichung, Taiwan
                [12 ]GRID grid.454211.7, ISNI 0000 0004 1756 999X, Traditional Chinese Medicine Pharmacy, Chang Gung Medical Foundation, , Linkou Chang Gung Memorial Hospital, ; Taoyuan, Taiwan
                [13 ]GRID grid.252470.6, ISNI 0000 0000 9263 9645, Department of Computer Science and Information Engineering, College of Computer Science, , Asia University, ; No. 500, Lioufeng Road, Wufeng, Taichung, 41354 Taiwan, ROC
                Article
                704
                10.1038/s41598-021-00704-w
                8564513
                34728662
                411ee015-163b-4f17-b251-0d5a6f95db60
                © The Author(s) 2021

                Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

                History
                : 9 February 2021
                : 8 October 2021
                Funding
                Funded by: FundRef http://dx.doi.org/10.13039/100008903, Ministry of Health and Welfare;
                Award ID: MOHW105-CMAP-M-114-000314
                Award Recipient :
                Funded by: FundRef http://dx.doi.org/10.13039/501100004391, China Medical University Hospital;
                Award ID: DMR-109-005
                Award Recipient :
                Funded by: FundRef http://dx.doi.org/10.13039/100010002, Ministry of Education;
                Award ID: CMRC-CMA-6
                Award Recipient :
                Categories
                Article
                Custom metadata
                © The Author(s) 2021

                Uncategorized
                databases,drug safety
                Uncategorized
                databases, drug safety

                Comments

                Comment on this article